Total Payments
$10,362
2024 Payments
$528.39
Companies
29
Transactions
204
Medicare Patients
9,033
Medicare Billing
$496,260
Payment Breakdown by Category
Food & Beverage$5,923 (57.2%)
Travel$4,350 (42.0%)
Education$88.71 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,923 | 190 | 57.2% |
| Travel and Lodging | $4,350 | 12 | 42.0% |
| Education | $88.71 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $4,539 | 35 | $0 (2020) |
| Edwards Lifesciences Corporation | $2,727 | 43 | $0 (2023) |
| Medtronic, Inc. | $663.34 | 13 | $0 (2024) |
| PFIZER INC. | $287.21 | 14 | $0 (2024) |
| Abbott Laboratories | $271.27 | 7 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $210.30 | 14 | $0 (2024) |
| ShockWave Medical, Inc | $199.49 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $187.42 | 12 | $0 (2024) |
| Boston Scientific Corporation | $183.22 | 8 | $0 (2024) |
| Amarin Pharma Inc. | $138.15 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $528.39 | 20 | Medtronic, Inc. ($155.61) |
| 2023 | $438.77 | 16 | ShockWave Medical, Inc ($199.49) |
| 2022 | $1,437 | 37 | Edwards Lifesciences Corporation ($817.76) |
| 2021 | $1,091 | 45 | Medtronic, Inc. ($375.99) |
| 2020 | $501.14 | 20 | Edwards Lifesciences Corporation ($209.51) |
| 2019 | $3,833 | 49 | Medtronic Vascular, Inc. ($2,141) |
| 2018 | $106.14 | 3 | Abbott Laboratories ($83.05) |
| 2017 | $2,426 | 14 | Medtronic Vascular, Inc. ($2,233) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: General - Therapies_IC | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardiology | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/22/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/27/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Cardiology | ||||||
| 06/06/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Not Applicable | ||||||
| 06/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: General - Therapies_IC | ||||||
| 05/30/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Cardiovascular | ||||||
| 05/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/11/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/02/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $155.61 | General |
| Category: Renal Denervation System | ||||||
| 03/11/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Cardiology | ||||||
| 01/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/22/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Cardiology | ||||||
| 11/18/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/15/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 11/09/2023 | Teleflex LLC | GUIDELINER (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Interventional Access | ||||||
| 11/01/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $5.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,490 | 3,214 | $647,464 | $133,815 |
| 2022 | 31 | 2,820 | 3,416 | $568,142 | $125,783 |
| 2021 | 30 | 2,361 | 2,883 | $584,828 | $141,484 |
| 2020 | 21 | 1,362 | 1,644 | $381,959 | $95,179 |
Total Patients
9,033
Total Services
11,157
Medicare Billing
$496,260
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 398 | $109,848 | $35,704 | 32.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 129 | 252 | $47,124 | $14,516 | 30.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 99 | 100 | $61,733 | $13,615 | 22.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 235 | 248 | $133,176 | $12,604 | 9.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $35,700 | $8,330 | 23.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 990 | 1,295 | $55,037 | $7,573 | 13.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 68 | 71 | $25,134 | $6,752 | 26.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 40 | 41 | $34,809 | $6,727 | 19.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 18 | $29,448 | $6,020 | 20.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 32 | $16,800 | $4,099 | 24.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 23 | 23 | $16,974 | $3,504 | 20.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 255 | 350 | $27,689 | $3,243 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $8,505 | $2,282 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 24 | $6,456 | $2,108 | 32.7% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 13 | 18 | $10,811 | $1,424 | 13.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,206 | $1,316 | 25.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $4,872 | $1,115 | 22.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 17 | 17 | $4,165 | $946.56 | 22.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 58 | 61 | $8,479 | $541.07 | 6.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 23 | 25 | $1,850 | $464.75 | 25.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 40 | 48 | $1,248 | $403.20 | 32.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 20 | 20 | $1,440 | $318.20 | 22.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 20 | 20 | $960.00 | $209.40 | 21.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 390 | 392 | $102,681 | $20,321 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 201 | $47,759 | $17,721 | 37.1% |
About Dr. Glynne Edwards, M.D
Dr. Glynne Edwards, M.D is a Cardiovascular Disease healthcare provider based in Fremont, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2010. The National Provider Identifier (NPI) number assigned to this provider is 1114234895.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Glynne Edwards, M.D has received a total of $10,362 in payments from pharmaceutical and medical device companies, with $528.39 received in 2024. These payments were reported across 204 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($5,923).
As a Medicare-enrolled provider, Edwards has provided services to 9,033 Medicare beneficiaries, totaling 11,157 services with total Medicare billing of $496,260. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Fremont, NE
- Active Since 09/02/2010
- Last Updated 10/05/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114234895
Products in Payments
- CoreValve Evolut (Device) $2,450
- Resolute (Device) $2,393
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,633
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $699.58
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $238.61
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $199.49
- VYNDAQEL (Drug) $188.90
- ENTRESTO (Drug) $187.42
- CAMZYOS (Drug) $166.55
- SYMPLICITY G3 (Device) $155.61
- Vascepa (Drug) $138.15
- (6366) Sync (Device) $113.72
- COREVALVE EVOLUT R (Device) $108.75
- ELIQUIS (Drug) $104.57
- NEXLETOL (Drug) $100.70
- CARDIOMEMS (Device) $96.16
- Impella (Device) $96.00
- LifeVest (Device) $95.27
- WATCHMAN FLX (Device) $91.99
- Asahi Fielder coronary guide wire (Device) $83.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fremont
Rajesh Suri, Md, MD
Cardiovascular Disease — Payments: $214,319
Cardiovascular Disease $214,319
Pradeep Kumar, Md Facc Fscai, MD FACC FSCAI
Cardiovascular Disease — Payments: $62,415
Cardiovascular Disease $62,415
Timothy Tsoi, M.d, M.D
Cardiovascular Disease — Payments: $32,104
Cardiovascular Disease $32,104
Carl Carlson, M.d, M.D
Cardiovascular Disease — Payments: $13,230
Cardiovascular Disease $13,230
Dr. Karim Hussain, Md, MD
Cardiovascular Disease — Payments: $6,670
Cardiovascular Disease $6,670
Romesh Japra, M.d, M.D
Cardiovascular Disease — Payments: $6,285
Cardiovascular Disease $6,285